hydroxyproline has been researched along with sermorelin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hümmelink, R; Rohwedder, R; Sippell, WG | 1 |
| Cai, R; Delcroix, G; Griswold, AJ; Jackson, RM; Lazerson, A; Mirsaeidi, M; Schally, AV; Wangpaichitr, M; Zhang, C | 1 |
2 other study(ies) available for hydroxyproline and sermorelin
| Article | Year |
|---|---|
Nine months' subcutaneous therapy with synthetic growth hormone releasing factor in children with short stature.
Topics: Adolescent; Body Height; Child; Child, Preschool; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hydroxyproline; Insulin-Like Growth Factor I; Male; Peptide Fragments; Sermorelin | 1987 |
Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin.
Topics: Animals; Bleomycin; Cells, Cultured; Cytoprotection; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Gene Expression Regulation; Growth Hormone-Releasing Hormone; Hormone Antagonists; Hydroxyproline; Inflammation Mediators; Lung; Male; Mice, Inbred C57BL; Pneumonia; Pulmonary Fibrosis; Sermorelin; Signal Transduction | 2019 |